Mahamaya Lifesciences Submits Monitoring Agency Report for September 2026
Mahamaya Lifesciences Ltd 路 Others (Uncategorized) 路 13 Nov 2026, 11:10 pm
Mahamaya Lifesciences Submits Monitoring Agency Report for September 2026 Mahamaya Lifesciences submitted its Monitoring Agency Report issued by Infomerics Valuation and Rating for the period ended 30th Sep'26, showing nil deviation in IPO proceeds utilization. Out of Rs. 61.96 crore net proceeds raised, the company utilized Rs. 32.72 crore cumulatively through Q2FY27 (including Rs. 1.03 crore in Q1FY27 and Rs. 2.52 crore in Q2FY27), leaving Rs. 29.24 crore unutilized in fixed deposits and monitoring accounts. The Board has rescheduled the deployment timeline for unutilized capex proceeds up to 31st Mar'28 due to phased plant execution.
Original exchange filing (PDF)
More announcements from Mahamaya Lifesciences Ltd
- Mahamaya Lifesciences Limited has informed the Exchange about Schedule of Meet to be held on Thursday, November 19, 2026 at 04.00 PM 路 19 Nov 2026
- Financial Results for the half year ended September 30, 2026 路 13 Nov 2026
- Outcome of Board meeting held on Today i.e. November 13, 2026 路 13 Nov 2026
- Mahamaya Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve unaudited financials .... 路 13 Nov 2026
- Submission of Non-Applicability of Compliance of Corporate Governance as required under Regulation 27(2) of SEBI (LODR) Regulations, 2015 路 29 Oct 2026
- Publication of Executive Interview in AgroPages Magazine (2026 India Focus Issue) 路 09 Oct 2026
- Appointment of Dr. Bhagirath Choudhary as Independent Director, Re-appointment of Dr. Charudatta Digambar Mayee as Independent Director, Re-appointment of Mr. Gopal Krishna Raju as Independent .... 路 30 Sept 2026
- Mahamaya Lifesciences Limited has informed the exchange regarding the voting results and scrutinizer report of the 24th Annual General Meeting held on September 29, 2026 路 30 Sept 2026
